Luminicell is a biotechnology company based in Singapore that is at the forefront of developing advanced biocompatible fluorescent probes. Specializing in long-term live cell imaging and diagnostics applications, Luminicell offers exceptional sensitivity and accuracy in their products. With their patented encapsulation platform technology, Luminicell manufactures fluorescent lipid nanoparticles that are combined with their groundbreaking Aggregation-Induced Emission (AIE) molecular, known as AIEdots.

These ultra-bright fluorescent trackers provide outstanding photostability, allowing for continuous monitoring of biological processes in both in vitro and in vivo applications. Luminicell's goal is to provide researchers and scientists with the best performing fluorescent nanoparticles on the market, unlocking valuable information and yielding superior results in the field of biomedical research. Their platform technology is highly customizable, allowing users to tailor the nanoparticles to their specific application needs.

Luminicell is a wholly owned subsidiary of Nanolumi, further solidifying their expertise in the field. Experience the future of bio-imaging and diagnostics with Luminicell's innovative products